Results 221 to 230 of about 493,419 (345)

Emerging toxicological awareness of per- and polyfluoroalkyl substances: the rising concern over 'forever chemicals'.

Dis Model Mech
DeWitt JC, Goldenman G, Lohmann R, Ng CA, Wang Z.   +4 more
europepmc   +1 more source

Heat stress and social dialogue in Greece. [PDF]

Ind Health
Koukoulaki T, Georgiadou P, Kapsali K.
europepmc   +1 more source

Structural Consequences of Cross-border Company Seat Transfers within the EU in the Latest Court of Justice Case law (Polbud Case - C-106/16)

, 2019
Arnaud Van Waeyenberge, Julie Benedetti
openalex   +1 more source

Pharmacokinetics, safety, tolerability and fluorescence imaging of nizaracianine triflutate administered in three divided doses to healthy volunteers

British Journal of Clinical Pharmacology, EarlyView.
Aim Fluorescence‐guided surgery enhances intraoperative visualization of anatomical structures. Nizaracianine is a near‐infrared fluorescent agent that is exclusively renally cleared in animal models. It enables real‐time ureteral imaging and identification, potentially reduces risk of injury and facilitates assessment before surgical closure.
Lisanne K. A. Neijenhuis, Cedric M. W. Pesch, John V. Frangioni, Alexander L. Vahrmeijer, Jacobus Burggraaf, Naomi B. Klarenbeek   +5 more
wiley   +1 more source

Analysis of Legislative and Regulatory Frameworks Governing Community Pharmacy in Bulgaria and North Macedonia. [PDF]

Pharmacy (Basel)
Todorova A, Ivanova M, Pesheva M, Miceva D, Angelovska B.   +4 more
europepmc   +1 more source

Corporate Human Rights Protection in EU Competition Law Enforcement - The Standard of Protection of Companies’ Rights in the Light of ECHR

, 2016
Tamar Khuchua
openalex   +1 more source

Zuranolone: A case study in (regulatory) rush to judgement?

British Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove, Milutin Kostic, Barbara Mintzes, Gianna D'Ambrozio, Allen Shaughnessy   +4 more
wiley   +1 more source

Not all information is equally important: informed consent to genetic testing for hereditary cancer. [PDF]

J Cancer Res Clin Oncol
Thomas P, Asmussen S, Klein K, Straub N, Stegen S, Kowalski C, Schüürhuis S, Speiser D, Feufel MA, Kendel F.   +9 more
europepmc   +1 more source

Activism in the arts: Co‐researching cultural inequalities with young people during the COVID‐19 pandemic

British Educational Research Journal, EarlyView.
Abstract This paper explores the growing influence of young people's activism in UK museums and its educational implications. It draws on a five‐year collaborative programme (2019–2023) with young people of colour (16–28) in a university museum setting, focusing on a Young Collective established to address cultural inequalities.
Sadia Habib
wiley   +1 more source